Collegium Pharmaceutical, Inc. COLL Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s total operating expenses?
- Collegium Pharmaceutical, Inc. (COLL) reported total operating expenses of $86.35M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s total operating expenses changed year-over-year?
- Collegium Pharmaceutical, Inc.'s total operating expenses increased by 14.2% year-over-year, from $75.64M to $86.35M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s total operating expenses has grown at a 20.8% compound annual growth rate (CAGR), from $132.99M to $283.62M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.